Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

in response to

Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

narmac

posted on Sep 27, 2024 11:55AM

Hey Narmac

i agree 100% with your statements

Anyone want to forward to the both Don McCaffrey and the BOD all the Biotech IPO and deals you linked to say what bullshit that the market right now is so difficult to get a BP deal

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply